≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Abnormal findings in secretions and smears from cervix uteri vagina vulva

MESH PheWeb

R18_ABNORMAL_FINDI_SECRE_SMEARS_CERVIX_UTERI_VAGINA_VULVA

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 R87
Cause of death: ICD-10 R87

15569

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10 ; C.O.D: 10

15569

diagram downward connector

Check minimum number of events None

15569

diagram downward connector

Include endpoints None

15569

diagram downward connector
R18_ABNORMAL_FINDI_SECRE_SMEARS_CERVIX_UTERI_VAGINA_VULVA

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF4
Parent code in ICD-10 R8[3-9]
Name in latin Reperta abnormia in speciminibus ex organis genitalibus femininis

Similar endpoints

↥

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 15569 15568 -
Unadjusted prevalence (%) 4.38 7.85 -
Mean age at first event (years) 40.98 40.97 -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.54 [1.08, 2.18] 1.6e-2 311
15 years 0.01 1.26 [0.92, 1.74] 1.5e-1 148
5 years 0.00 2.47 [1.76, 3.46] 1.5e-7 67
1 year 0.00 3.61 [2.11, 6.16] 2.6e-6 17

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: R18_ABNORMAL_FINDI_SECRE_SMEARS_CERVIX_UTERI_VAGINA_VULVA – Abnormal findings in secretions and smears from cervix uteri vagina vulva
GWS hits:

Survival analyses between endpoints

↥

Plot

before Abnormal findings in secretions and smears from cervix uteri vagina vulva
after Abnormal findings in secretions and smears from cervix uteri vagina vulva

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Abnormal findings in secretions and smears from cervix uteri vagina vulva

↥